Iron is an integral component of redox chains and many enzymes and, thus, is indispensable for metabolism, energy transfer and other processes. [1] In fact, iron is an essential element not only for higher organismsb ut also for most microbes. However,t he availability of free iron ions in at ypical bacterial environment is rather low,s imply due to the very limiteds olubility of Fe III of just 10 À18 m in water at neutralp H. [2] Bacterial pathogens that proliferatei nside ah ost organism face the same problem;i nf act, in vertebrates iron is specifically bound to transport proteins such as transferrino rl actoferrin in body fluids or to intracellular proteins such as hemoglobin and ferritin. On the one hand, this complexation circumventst he low solubilityo ff ree Fe III ;o nt he other hand, it protects Fe III from reduction to Fe II ,w hich can induce the formation of toxic hydroxyl radicals in the Fentonreaction.
Apart from this, the tight regulation of iron availability can be perceived as an antimicrobial strategy as it restricts potential pathogens' access to this essential element, ac oncept that was named" nutritional immunity". [3] In humanp lasma, for example, the concentration of free Fe III is only about1 0 À24 m, essentially duet ot he complexation by transferrin. [4] However, to ensure an iron supply,m icrobes have evolveda ne laborate strategy: [5] They secrete so-calleds iderophores, smallo rganic molecules that chelate Fe III with extremely high affinity.F or example, enterobactin( Ent) and bacillibactin (BB), which are produced by commensal bacteria including Escherichia coli, complex iron with extraordinary formation constants (K f )o f 10 49 and 10 47 m À1 ,respectively. [6] Both Ent and BB belong to the catecholate family of siderophores and contain ac yclic trilactone backbone with three 2,3dihydroxybenzoyl side chains that can tightly coordinate acentral ferric ion ( Figure 1 ). [7] BB differs from Ent mainly by the additional glycyl spacer that links each catecholate moiety to the cyclic backbone (apart from extra methyl groups there).O ther siderophore complexes have lower formation constants( e.g., aerobactin, K f % 10 28 m À1 ), [8] but this is still sufficient to acquire iron in human plasma considering that transferrin has al ower K f of 10 22 m À1 . [4] Once formed, ferric siderophore complexes are imported via specific receptors into the bacterial cell, where iron is finally released by enzymatic reduction of Fe III to Fe II or degradation of the siderophore. [7] Thus, bacterial iron acquisition through siderophores can be very effective,a nd their secretiono ften significantly contributes to virulence. [9] Conversely,d ue to their critical role for pathogens, siderophores serve as targets for the innate immune system to suppressb acterial growth. [5] In this context, one of the most important proteins is siderocalin (Scn), also known as lipocalin 2( Lcn2) or neutrophil gelatinase-associated lipocalin (NGAL). [10] Scn is an abundant human plasma protein that tightly binds several siderophoresf rom the catecholatetype familyw ith sub-nanomolar K D values, in particular Ent·Fe III and BB·Fe III .Furthermore, it recognizess ome of the carboxymycobactins secretedb yMycobacterium tuberculosis,w hich com-Iron acquisition mediated by siderophores, high-affinity chelators for which bacteria have evolved specific synthesis and uptake mechanisms, plays ac rucial role in microbiology and in host-pathogen interactions. In the ongoing fight against bacteriali nfections, this area has attracted biomedical interest. Beyonds everala pproaches to interferewith siderophore-mediated iron uptake from medicinal and immunochemistry,t he development of high-affinity protein scavengerst hat tightly complex the siderophores produced by pathogenic bacteria has appeared as an ovel strategy.S uch binding proteins have been engineered based on siderocalin-also known as lipo-calin 2-an endogenoush uman scavenger of enterobactin and bacillibactin that controlst he systemic spreading of commensal bacteria such as Escherichia coli. By using combinatorial protein design,s iderocalin was reshaped to bind severals iderophores from Pseudomonas aeruginosa and, in particular,p etrobactin from Bacillusa nthracis,n oneo fw hich is recognized by the natural protein. Such engineered versions of siderocalin effectively suppress the growth of correspondingp athogenic bacteria by depriving them of their iron supplya nd offer the potentialt oc omplementa ntibiotic therapy in situations of acute or persistentinfection. plex iron in ad ifferent mannerb yu sing ap henyloxazoline and two hydroxamate groups ( Figure 1 ). [11] It is generally assumed that the acute-phase protein Scn acts as an antimicrobial agenti nh uman plasma and effectively prevents the systemics preadingo fb acteria that dependo nc orresponding siderophores.I ndeed, Lcn2-deficient transgenic mice showedastrongly decreased resistance against ac linicals train of Ent-dependent E. coli as compared to wild-type mice, whereas applicationo fr ecombinantL cn2 to the acute-phase serum of the knock-out mice suppressed bacterial growth. [12] Interestingly,i ron depletion by Lcn2 could be bypassed by application of ferrichrome, as iderophore that is not produced by E. coli (or bound by Lcn2) but can be imported by this bacterium. The role of human Scn in the defense against bacterial infections was further corroborated in ar ecent study with HIV patients as wella sh ealthyi ndividuals infectedw ith M. tuberculosis (whose virulence depends on iron acquisition through carboxymycobactin) by detecting strong up-regulation of serum Scn in active tuberculosis for both groups. [13] Apart from that, human tear lipocalin (Tlc), also known as lipocalin 1( Lcn1), is another member of the lipocalin family with antimicrobial activity. [14] Tlc is abundant in tear fluid as well as on surfaces of the respiratory tract and binds ab road spectrum of siderophores,i ncluding Ent, aerobactin, ferrioxamine Ba nd several fungal siderophores, yet with lower affinity than Scn. [15] 
Pathogenic Bacteria and Their Stealth Siderophores
From an evolutionary point of view,t he competitionf or iron has had as trongi mpacto np athogen-host interactions and constantly forces adaptation by both sides. [16] The appearance of an Scn-based defensem echanism in highero rganismsp rovided those pathogens that produce siderophores that are not recognized by Scn with an advantage. Such "stealth siderophores" [11b] exhibit structural features that preclude bindingt o the ligand pocket of this lipocalin. Salmochelins, for example, are derivatives of Ent that carry one or two C-linked glucose substituents on the catechol groups ( Figure 1 ) [17] and cannot form ac omplexw ith Scn due to steric hindrance. [18] Thus, corresponding strains of Salmonella spp., Klebsiella pneumoniae and E. coli evade the human innate immune system simply by making an ordinary siderophore more bulky.I nterestingly, monoglucosylated (but not diglucosylated)s almochelin is bound by the extracellularf atty-acidb inding protein (Ex-FABP), which is found in chicken and also binds Ent·Fe III with its enlarged pocket, providing sufficient space to accommodate the protruding glucose substituent. [19] It has been hypothesized that this protein featuree volvedf rom the specific interaction between chickena nd their pathogens, in particular Salmonella enterica. [20] Another stealth siderophorei sp etrobactin (PB), which was originally isolated from Marinobacter hydrocarbonoclasticus,a n oil-degrading microbe. [21] More importantly,P Bi sa lso produced by pathogenic strains of Bacillus cereus and Bacillus anthracis. [22] As infection with B. anthracis can be fatal, ab etter understanding of the PB-based iron-acquisition system is of great interest. [23] PB contains two 3,4-dihydroxy catecholates insteado ft he 2,3-dihydroxy catecholatesf ound in Ent andB B; togetherw ith the bridging citryl moietya nd spermidine spacer groups these lead to ac ompletely different geometry of the ferric complex ( Figure 1 ). [24] Thus, PB·Fe III is not bound by Scn and escapes the innate immune system in humans. [11b] Accordingly,t he synthesis of PB is crucial for the virulenceo ft hese bacteria. [25] The affinity of PB for iron is similar to that of BB (estimated K f = 10 43 vs. 10 47 m À1 ), [26] whereas it seems that PB is more efficient in abstracting iron from diferric transferrin. [27] Strains of Pseudomonas also produce two types of siderophore that are not recognized by Scn. [28] One of them is pyochelin ( Figure 1 ), which contains at hiazolinea nd ap henolate moiety andb elongs to the mixed-type siderophores.F urthermore,t hese bacteria secrete pyoverdines,aclass of highlyd iverse siderophorest hat comprise three parts:aconserved fluorescent dihydroquinoline moiety,a na cyl side chain attached to its amino group, and av ariable peptidec hain with 6-12 amino acidr esidues. More than 50 pyoverdines have been identified from different strains of Pseudomonas. [29] Pyoverdines secreted by Pseudomonas aeruginosa,a no pportunistic human pathogen, can be grouped into three types each carrying a distinct peptidec hain. [29, 30] Furthermore, the siderophores from each type varyi nt heir acyl chain,t hus giving rise to ar emarkable diversity in this iron-uptake system.N otably,c ertain strainso fP. aeruginosa produce one type of pyoverdine but Martin can also import ferric complexes of siderophores secreted by other bacteria;t his kind of "iron piracy" adds another component to the biological competition for iron. [31] 3. Iron-Acquisition SystemsasT argets for Antimicrobial Strategies Bacterialp athogens constitute as erious threat to mankind, and this problem is aggravated by ag rowing resistance to availablea ntibiotics. [32] Thus, there is an increasingn eed for novel antimicrobial targets andt herapies. In this context, ironacquisition systemsh ave attracted considerable attention in recent years. [33] In as o-called "Trojan horse" strategy that makes use of siderophore-antibiotic conjugates, bacterial siderophore import systems have been employed to deliver toxic agents specifically to microbes. [34] In principle, this strategy only targets bacteria that express the corresponding transporter,l eaving unrelatedb acteriaa sw ell as host cells unaffected. Other approaches aim to develop chemical inhibitors of siderophore biosynthesis. [35] Baulamycins, for example, are ar ecently discovered class of antibiotics that weres hown in vitro to inhibit ap articular step in the biosynthesis of petrobactin, including the structurallyr elateds taphyloferrin. [36] As ubsequent study,h owever,c ame to the conclusion that the antibiotic effect of these amphiphilic compounds is mainly due to an inductiono fc ell lysis. [37] Ad ifferent strategy involves siderophore-based immunization. For example, Ent was conjugated to the cholera toxin subunit Ba sa ni mmunogenic carrier protein and applied in a mousem odel to elicit IgA antibodies both against the Ent hapten and the structurally relateds almochelins. [38] Indeed, such immunized mice contained fewer Salmonella in their in- testines when infectedw ith this bacterial pathogen, apparently due to the neutralization of the salmochelin stealth siderophore. Similarly,avaccine based on yersiniabactin and aerobactin was shown to protect against ap athogenic strain of E. coli in amouse model of urinary tract infection. [39] Hence, immunization with siderophores (or their conjugates) might offer ap romising way to protect hosts from infectious bacteria.
Neutralization of Siderophores by Using Engineered Binding Proteins Based on Scn
Our laboratory has pioneered the engineering of novel binding proteins based on the lipocalin scaffold, including Scn/Lcn2, yieldings o-called Anticalin molecules (registered trademarko f Pieris Pharmaceuticals GmbH). [40] Lipocalins are small proteins with a b-barrel fold made of eight antiparallel strandst hat are arrangedi nacircularm anner.T hese b-strands are connected pairwise by four loops, thus creatingaligand pocket at the open end. The shape of this bindings ite, which specifically accommodates Ent and BB in the case of Scn, as explained above,varies considerably among the many different members of the lipocalin family. [14, 41] In fact, this structurally variable region resembles the hypervariable loop region of antibodies. [42] By employing targeted random mutagenesis together with combinatorial selection techniques (phage display,c olony screening, high-throughput ELISA,a nd the like), Anticalins with novel specificities and high affinitiesc an be generated against as eries of molecular targets,n ot only haptens but also peptides and proteins. [40a, 43] For example, in the context of metal chelators, we have previously developed variants of Scn with picomolara ffinity forl anthanide metal complexes of CHX-A''-DTPA, as ynthetic chelator that is of interest for positrone mission tomography (PET) imaging andr adioimmunotherapy (Figure 1 ). [44] Based on these encouraging results, we recently set out to reshape Scn in order to achieveb inding activity for Fe III complexes of stealth siderophores that play ar ole in infectious diseases.A samodel target we chose PB·Fe III ,w hich is of particular biomedical relevance. [45] This siderophorei ss ecreted by B. anthracis, [46] as explained above,ahighly infectious microbe that also represents ab iothreat. [47] Of note, B. anthracis produces BB as as econd siderophore beside PB;h owever,B Bi ss equestered by natural Scn. Consequently,a dditional neutralization of PB by ac ognate engineeredl ipocalin should fully block iron acquisition by this bacterial pathogen, thus inhibiting growth (Figure 2) .
To select ab inding protein specific for PB·Fe III ,w eu sed a previously described gene library of Scn (Lcn2) with 20 randomized amino acid positions that surround the ligand pocket at the open end of the b-barrel. [48] The chemical synthesis of PB, and also of ab iotinylated derivative that wasr equired for the selection process, was carriedo ut according to published procedures. [49] Selection from the naïve randomized lipocalin library was performed by using phagemid display as well as af ilter sandwich colonys creening assay. [43b] The Lcn2 variant with the best PB·Fe III -binding activity resulting from this procedure was subjected to two rounds of affinity maturation by partially randomizing the major coding region followed by selection via phagemid display and bacterial surface display. [45] Finally, one mutant was identified that not only exhibited ar emarkable affinity towards PB·Fe III (K D = 21 AE 2pm)b ut also had lost the original binding activity of Scn towards Ent·Fe III .T herefore, this engineered lipocalin was dubbed petrocalin (Pcn). Pcn has distinct ligand-bindingc haracteristicsf rom Scn: it does not recognize Ent·Fe III ,s mallerc atecholate·Fe III complexes, or metal-free PB, thus exhibiting an entirely novel substrate specificity.
The X-ray crystal structure of Pcn in complex with PB·Ga III -a surrogate that is not light-sensitive like the Fe III complexyielded interesting insights into the binding mode ( Figure 3) ; [45] also, this was the first reported crystal structure of this siderophore. As anticipated from its chemical formula (cf. Figure 1 ), PB shows an extended, butterfly-like conformation that allowso ctahedral coordinationo fG a III (or Fe III )b yt he central carboxyl and hydroxy groups as well as the two 3,4-dihydroxybenzoyl moieties that are attached via flexible spermidine linkers. This configuration leads to an overall larger complex than Ent·Fe III and, in agreement with this differing molecular geometry,P cn has aw ider ligand pocket than Scn. Nevertheless, there are also similarities in the mode of siderophore binding between Pcn and Scn (Figure 3) . For example, the ligand pocket of Pcn hasa no verall positive charge, and two critical amino acid residues, Arg79 and Arg100, contact one of the catechol groups of PB·Fe III through cation-p interactions. This resembles the interaction between Ent·Fe III and Scn throught he three basic side chains of Arg81,L ys125 and Lys134. [11a] To investigate whether Pcn can suppress the growth of bacteria that depend on PB for iron acquisition, B. cereus F837/76 was chosen as am odel strain. This less harmful strain is closely related to pathogenic B. anthracis [50] and, likewise, secretes both BB and PB. [22] When B. cereus F837/76 was cultured in a low-ironm edium, growth wass trongly inhibited when both the engineered Pcn and recombinant Scn were added to the culture. This effect was decreased by supplementation with PB, or PB·Fe III ,i naconcentration-dependent manner.N otably,P cn had no significant effect when applied to the bacterial culture withoutS cn, or when ar elated strain of B. cereus that only dependso nB Bw as used. Taken together,t hese experiments providedc onvincing proof that Pcn exerts ab acterialg rowthinhibiting effect by neutralization of PB·Fe III .
The Potential of Engineered Lipocalins for Antibacterial Therapy
In conclusion, it has been demonstratedt hat human Scn, a natural protein from the innate immunes ystem, can be reshaped by protein design to effectively sequester as iderophore that is critical for supplying iron to ab acterial pathogen. The growth-limiting effect on relevant Bacillus strains observed in vitro suggestst hat it could be used to treat harmful bacterial infections, including anthrax,i nac linical setting. To thise nd, Pcn might be administered as ab iopharmaceutical by infusion, exertingi ts antibacterial activity in synergyw ith the endogenous Scn.
This proofo fc oncept opens wider applicationso fe ngineered lipocalins as siderophore scavengers to fight bacterial infections. In fact, siderophore-specific Anticalin proteins have also been developed as potentialt herapeutic candidates to treat infections by P. aeruginosa. [51] Four different Anticalins were selected with specificity for each of the three pyoverdine types (see above) as well as pyochelin and combined in a single fusion protein dubbed" Te tracalin". [52] In principle, this multispecific binding protein can neutralize all of the siderophores produced by clinically relevant strains of P. aeruginosa. The tetracalin was ablet oe radicate ac hronic P. aeruginosa infection in ar at model.P harmacokinetics tudies showedg ood lung exposure of the intravenously administered substance and acceptable half-life. These siderophore-specific Anticalin proteins can possibly be used in the managemento fc ystic fibrosis patientschronically infected by P. aeruginosa. [53] Generally,r eprogramming of lipocalins such as Scn offers an attractive strategy to scavenge stealth siderophores and, in this way, deprive bacteria of iron,ac oncept that might even be expandedt oa cquisition systemsf or other essential transition metals. [54] Corresponding engineered lipocalins should be usefult otreat bacterial infections as part of at herapeutic regimen, either alone, by complementing conventional antibiotics, or in combination with otherantimicrobialc ompounds. [33a] 
